Pages

▼
Showing posts with label antibody-drug conjugates. Show all posts
Showing posts with label antibody-drug conjugates. Show all posts
Friday, October 18, 2013

Deals Of The Week: Academic Drug-Discovery Alliance Capturing Industry's Notice

›
Nashville hosted the first annual conference of the Academic Drug Discovery Consortium It’s become a familiar story in biopharma, as...
Friday, June 28, 2013

Deals of the Week Gets Better Connected, Dips A Toe In Digital Health

›
Digital health is a bit of a catch-all. It encompasses everything from inexpensive exercise- and diet-recording gadgets to sophisticat...
Friday, April 05, 2013

Deals Of The Week Wonders Whether Heated Competition To Buy Ache Laboratorios Will Muddy The Brazilian Waters

›
Could a bidding war for Brazil’s privately held Ache Laboratorios do for Latin America what Abbott Laboratories’ gargantuan purchase of ...
Thursday, August 09, 2012

Financings Of The Fortnight: Idenix To Forge Ahead On HCV Combo After Novartis' Departure

›
Idenix Pharmaceuticals has been quite busy of late, on the fundraising front and elsewhere. A clinical-stage biotech with a market cap of...
Friday, June 15, 2012

Financings of the Fortnight: Less Talk, More Rock

›
Third Rock Ventures has topped itself. One of biotech’s few ready sources of early-stage capital, the firm has announced its backing of thr...
Friday, April 06, 2012

Financings of the Fortnight Hops Around

›
We’ve got a short attention span this week, what with magazine deadlines, an overnight trip to Seattle to help interview participants a...